Official title and information are available only for Plus and Premium subscribers.
Patent Pending Nucleic acid aptamers are nucleic acid species that have been engineered through repeated rounds of in vitro selection or equivalently, SELEX (systematic evolution of ligands by exponential enrichment) to bind to various molecular targets such as small molecules, proteins, nucleic acids, and even cells, tissues and organisms.
To see the additional information details please login and subscribe to a Plus or Premium account.
